Related Experiment Video
Updated: Jul 27, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Regulation of PD-L1 Trafficking from Synthesis to Degradation
Eyoel Yemanaberhan Lemma1, Anudari Letian2,3, Nasser K Altorki1,4,5
1Department of Cardiothoracic Surgery, Weill Cornell Medicine and NY Presbyterian Hospital, New York, New York.
Abstract:
Programmed death-ligand 1 (PD-L1) is a transmembrane ligand for the programmed cell death protein 1 (PD-1), a receptor that inhibits T-cell activity. The PD-L1/PD-1 immune checkpoint axis has been successfully targeted to enhance antitumor immune responses. Tethering PD-L1 to the membrane spatially restricts its ability to inhibit immune responses, and it provides for the acute and reversible modulation of PD-L1 plasma membrane density by regulation of its trafficking. PD-L1 has functions that are independent of its role as a ligand for PD-1, and control of PD-L1 residence in different intracellular compartments might contribute to the regulation of those activities. Thus, control of PD-L1 trafficking is emerging as a key feature of its biology. Herein, we focus on current understating of PD-L1 trafficking and review current attempts to therapeutically target this process in cancer cells to enhance antitumor immunity.
Insights
Targeting programmed death-ligand 1 (PD-L1) trafficking enhances antitumor immunity. Understanding PD-L1
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Programmed death-ligand 1 (PD-L1) interacts with programmed cell death protein 1 (PD-1) to inhibit T-cell activity.
- The PD-L1/PD-1 axis is a validated target for augmenting antitumor immune responses.
- PD-L1 exhibits functions beyond its PD-1 ligand role, influenced by intracellular localization.
Purpose of the Study:
- To review current understanding of PD-L1 trafficking.
- To explore therapeutic strategies targeting PD-L1 trafficking in cancer cells.
- To enhance antitumor immunity by modulating PD-L1 biology.
Main Methods:
- Literature review of PD-L1 trafficking mechanisms.
- Analysis of studies investigating PD-L1 regulation.
- Examination of therapeutic approaches targeting PD-L1.
Main Results:
- PD-L1 membrane tethering spatially restricts immune inhibition.
- Regulation of PD-L1 trafficking allows reversible modulation of its plasma membrane density.
- Intracellular compartmentalization of PD-L1 influences its non-ligand-dependent functions.
Conclusions:
- Control of PD-L1 trafficking is crucial for its biological activities.
- Targeting PD-L1 trafficking presents a promising strategy for cancer immunotherapy.
- Modulating PD-L1 dynamics can enhance immune responses against tumors.
Related Concept Videos
Regulation of Expression at Multiple Steps
Regulation of Nuclear Protein Sorting
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Abnormal Proliferation

